TNFRSF17 and neoplasm: In the RPMI8226 model, with lower BCMA expression, the tracer showed slightly reduced uptake of approximately 4% %ID/g in the femur, arm, and spine, but 8 %ID/g in the skull, where BLI confirmed substantial tumor localization (Figures S7A-B).